Breast cancer-related lymphedema and its treatment: how big is the financial impact?

ConclusionThis study is one of the first standardized high-quality health economic analyses of BRCL treatment in Europe. The present study indicates that the price tag of BCRL treatment in Belgium is high not only for the health insurance but also for the patientsClinical trial registration numberThe study makes part of a double-blind, multi-center, randomized controlled trial (EFforT-BCRL trial), which is registered inclinicaltrials.gov (NCT02609724). CME reference S58689, EudraCT Number 2015-004822-33.
Source: Supportive Care in Cancer - Category: Cancer & Oncology Source Type: research